10X Genomics, Inc.


	Shares		Value
COMMON STOCKS - 96.0%
Automobiles - 4.8%
Rivian Automotive, Inc., Class A ^(A) (B)		160,909		$ 4,447,525
Tesla, Inc. ^(B)		281,788		75,358,565

				79,806,090

Biotechnology - 1.2%
Alnylam Pharmaceuticals, Inc. ^(B)		11,336		2,215,054
Intellia Therapeutics, Inc. ^(B)		129,613		5,486,518
Moderna, Inc. ^(B)		12,931		1,521,462
ProKidney Corp. ^(B)		170,370		2,184,143
Roivant Sciences Ltd. ^(B)		652,279		7,814,303

				19,221,480

Broadline Retail - 4.8%
Coupang, Inc.		1,489,031		27,025,913
Global-e Online Ltd. ^(B)		568,046		25,590,472
MercadoLibre, Inc. ^(B)		21,236		26,291,230

				78,907,615

Capital Markets - 0.4%
Coinbase Global, Inc., Class A ^(B)		75,572		7,452,155

Chemicals - 0.5%
Ginkgo Bioworks Holdings, Inc. ^(A) (B)		3,155,884		7,921,269

Entertainment - 4.8%
ROBLOX Corp., Class A ^(B)		2,000,178		78,506,986

Financial Services - 6.3%
Adyen NV ^{(B) (C)}		32,039		59,526,404
Affirm Holdings, Inc. ^{(A) (B)}		1,322,057		25,634,685
Block, Inc. ^(B)		231,813		18,667,901

				103,828,990

Ground Transportation - 9.4%
Grab Holdings Ltd., Class A ^(B)		7,594,368		29,086,430
Uber Technologies, Inc. ^(B)		2,533,183		125,291,231

				154,377,661

Health Care Providers & Services - 3.3%
agilon health, Inc. ^{(A) (B)}		2,841,816		54,420,776

Health Care Technology - 1.0%
Doximity, Inc., Class A ^(B)		472,100		16,868,133

Hotels, Restaurants & Leisure - 10.9%
Airbnb, Inc., Class A ^(B)		520,306		79,185,370
DoorDash, Inc., Class A ^(B)		1,111,252		100,890,569

				180,075,939

IT Services - 20.5%
Cloudflare, Inc., Class A ^(B)		1,696,247		116,650,906
Shopify, Inc., Class A ^(B)		1,789,306		120,921,299
Snowflake, Inc., Class A ^(B)		563,918		100,213,868

				337,786,073

Leisure Products - 0.7%
Peloton Interactive, Inc., Class A ^(B)		1,182,462		11,481,706


	Shares		Value
COMMON STOCKS (continued)
Life Sciences Tools & Services - 2.3%
10X Genomics, Inc., Class A ^(B)		273,689		$ 17,236,933
Illumina, Inc. ^(B)		111,573		21,438,752

				38,675,685

Media - 7.4%
Trade Desk, Inc., Class A ^(B)		1,343,484		122,606,350

Pharmaceuticals - 4.3%
Royalty Pharma PLC, Class A		2,282,108		71,612,549

Software - 9.9%
Aurora Innovation, Inc. ^{(A) (B)}		5,120,805		16,796,240
Bills Holdings, Inc. ^(B)		639,382		80,140,140
Gitlab, Inc., Class A ^(B)		523,727		25,992,571
Procore Technologies, Inc. ^(B)		243,381		18,460,449
Samsara, Inc., Class A ^(B)		799,501		22,338,058

				163,727,458

Specialty Retail - 3.5%
Carvana Co. ^(B)		911,066		41,863,483
Wayfair, Inc., Class A ^{(A) (B)}		197,738		15,397,858

				57,261,341

Total Common Stocks (Cost $1,649,450,772)				1,584,538,256


OTHER INVESTMENT COMPANY - 2.4%
Securities Lending Collateral - 2.4%
State Street Navigator Securities Lending Trust - Government Money Market Portfolio, 5.28% ^(D)		39,265,720		39,265,720

Total Other Investment Company (Cost $39,265,720)				39,265,720


	Principal		Value
REPURCHASE AGREEMENT - 3.6%
Fixed Income Clearing Corp., 2.50%^(D), dated 07/31/2023, to be repurchased at $59,026,532 on 08/01/2023. Collateralized by U.S. Government Obligations, 0.13% - 4.50%, due 07/15/2026, and with a value of $60,198,749.		$ 59,018,334		59,018,334

Total Repurchase Agreement (Cost $59,018,334)				59,018,334

Total Investments Excluding Options Purchased (Cost $1,747,734,826)				1,682,822,310
Total Options Purchased - 0.1% (Cost $4,641,865)				2,019,845

Total Investments (Cost $1,752,376,691)				1,684,842,155
Net Other Assets (Liabilities) - (2.1)%				(35,399,249	)

Net Assets - 100.0%				$ 1,649,442,906

Transamerica Capital Growth (the “Fund”) is a series of the Transamerica Funds.

Transamerica Asset Management, Inc. (“TAM”) has been designated as the Fund’s valuation designee pursuant to Rule 2a-5 under the Investment Company Act of 1940, as amended, with responsibility for fair valuation subject to oversight by the Fund’s Board of Trustees. The net asset value of the Fund is computed as of the official close of the New York Stock Exchange (“NYSE”) each day the NYSE is open for business.

TAM utilizes various methods to measure the fair value of its investments on a recurring basis. Generally Accepted Accounting Principles in the United States of America establishes a hierarchy that prioritizes inputs to valuation methods. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. The three levels (“Levels”) of inputs of the fair value hierarchy are defined as follows:

Level 1 — Unadjusted quoted prices in active markets for identical securities.

Level 2 — Inputs, other than quoted prices included in Level 1, which are observable, either directly or indirectly. These inputs may include quoted prices for the identical instrument on an inactive market, prices for similar instruments, interest rates, prepayment speeds, credit risk, yield curves, default rates, and similar data.

Level 3 — Unobservable inputs based on the best information available in the circumstances, to the extent observable inputs are not available, which may include TAM’s own assumptions used in determining the fair value of the Fund’s investments and derivative instruments.

The inputs used to measure fair value may fall into different Levels of the fair value hierarchy. In such cases, for disclosure purposes, the Level in the fair value hierarchy that is assigned to the fair value measurement of a security is determined based on the lowest Level input that is significant to the fair value measurement in its entirety. Certain investments that are measured at fair value using Net Asset Value (“NAV”) per share, or its equivalent, using the “practical expedient” have not been classified in the fair value Levels. The hierarchy classification of inputs used to value the Fund’s investments at July 31, 2023, is disclosed within the Investment Valuation section of the Schedule of Investments.

The availability of observable inputs can vary from security to security and is affected by a wide variety of factors, including, but not limited to, the type of security, whether the security is new and not yet established in the marketplace, the liquidity of markets, and other characteristics particular to the security. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised in determining fair value is generally greatest for instruments categorized in Level 3. Due to the inherent uncertainty of valuation, the determination of values may differ significantly from values that would have been realized had a ready market for investments existed, and the differences could be material.

Fair value measurements: Descriptions of the valuation techniques applied to the Fund’s significant categories of assets and liabilities measured at fair value on a recurring basis are as follows:

Equity securities: Securities are stated at the last reported sales price or closing price on the day of valuation taken from the primary exchange where the security is principally traded. To the extent these securities are actively traded and valuation adjustments are not applied, they are categorized in Level 1 of the fair value hierarchy. Equities traded on inactive markets or valued by reference to similar instruments are generally categorized in Level 2 or Level 3 if inputs are unobservable.

Foreign equity securities: Securities in which the primary trading market closes at the same time or after the NYSE, are valued based on quotations from the primary market in which they are traded and are categorized in Level 1. Because many foreign securities markets and exchanges close prior to the close of the NYSE, closing prices for foreign securities in those markets or on those exchanges do not reflect the events that occur after that close. Certain foreign securities may be fair valued using a pricing service that considers the correlation of the trading patterns of the foreign security to the intraday trading in the U.S. markets for investments such as American Depositary Receipts, financial futures, or ETFs and the movement of certain indices of securities based on a statistical analysis of their historical relationship; such valuations generally are categorized in Level 2.

Securities lending collateral: Securities lending collateral is invested in a money market fund which is valued at the actively traded NAV and no valuation adjustments are applied. Securities lending collateral is categorized in Level 1 of the fair value hierarchy.

Repurchase agreements: Repurchase agreements are valued at cost, which approximates fair value. To the extent the inputs are observable and timely, the values are generally categorized in Level 2 of the fair value hierarchy.

Derivative instruments: Centrally cleared or listed derivatives that are actively traded are valued based on quoted prices from the exchange and are categorized in Level 1 of the fair value hierarchy. Over-the-counter (“OTC”) derivative contracts include forward, swap, swaption, and option contracts related to interest rates, foreign currencies, credit standing of reference entities, equity prices, or commodity prices. Depending on the product and the terms of the transaction, the fair value of the OTC derivative products are modeled taking into account the counterparties’ creditworthiness and using a series of techniques, including simulation models. Many pricing models do not entail material subjectivity because the methodologies employed do not necessitate significant judgments and the pricing inputs are observed from actively quoted markets, as is the case of interest rate swap and option contracts. The majority of OTC derivative products valued by the Fund using pricing models fall into this category and are categorized within Level 2 of the fair value hierarchy or Level 3 if inputs are unobservable.


Description	Counterparty		Exercise Price			Expiration Date		Notional Amount/ Number of Contracts			Premiums Paid			Value
Put - USD vs. CNH		JPM		USD	7.43		01/17/2024		USD	279,788,523		$	1,317,057		$	798,517
Put - USD vs. CNH		SCB		USD	7.57		05/24/2024		USD	340,798,209			1,441,917			1,215,286
Put - USD vs. CNH		SCB		USD	7.57		08/23/2023		USD	418,270,405			1,867,159			5,856
Put - USD vs. CNH		GSI		USD	7.87		10/09/2023		USD	3,267,527			15,732			186

Total												$	4,641,865		$	2,019,845


(A)		All or a portion of the securities are on loan. The total value of all securities on loan is $70,176,716, collateralized by cash collateral of $39,265,720 and non-cash collateral, such as U.S. government securities and irrevocable letters of credit, of $33,903,098. The amount of securities on loan indicated may not correspond with the securities on loan identified because securities with pending sales are in the process of recall from the brokers.
(B)		Non-income producing securities.
(C)		Security is exempt from registration pursuant to Rule 144A of the Securities Act of 1933. Security may be resold as transactions exempt from registration, normally to qualified institutional buyers. At July 31, 2023, the value of the 144A security is $59,526,404, representing 3.6% of the Fund’s net assets.
(D)		Rates disclosed reflect the yields at July 31, 2023.
(E)		There were no transfers in or out of Level 3 during the period ended July 31, 2023. Please reference the Investment Valuation section of the Notes to Schedule of Investments for more information regarding investment valuation and pricing inputs.


CNH		Chinese Yuan Renminbi (offshore)
USD		United States Dollar


GSI		Goldman Sachs International
JPM		JPMorgan Chase Bank, N.A.
SCB		Standard Chartered Bank


	Level 1 - Unadjusted Quoted Prices		Level 2 - Other Significant Observable Inputs		Level 3 - Significant Unobservable Inputs		Value
ASSETS
Investments
Common Stocks	$	1,525,011,852	$	59,526,404	$	—	$	1,584,538,256
Other Investment Company		39,265,720		—		—		39,265,720
Repurchase Agreement		—		59,018,334		—		59,018,334
Over-the-Counter Foreign Exchange Options Purchased		—		2,019,845		—		2,019,845

Total Investments	$	1,564,277,572	$	120,564,583	$	—	$	1,684,842,155


Transamerica Funds			Page 1


Transamerica Funds			Page 2


Transamerica Funds			Page 3


Transamerica Funds			Page 4